Simulations Plus Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: February 27th, 2022
Here are a few of the most interesting Simulations Plus statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Simulations Plus Facts
- Simulations Plus Website: Official Website
- Year Simulations Plus was Founded: 1996
- Simulations Plus Headquarters: Lancaster, CA
- Simulations Plus Founder(s): Walter Woltosz
- Current Simulations Plus Chief Executive: Shawn O'Connor
- Simulations Plus Subsidiaries / Brands: Cognigen, DILIsym
What is Simulations Plus?
Simulations Plus, Inc., is a premier developer of drug discovery/development software and a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions and quantitative systems pharmacology models for drug-induced liver injury, drug-induced kidney injury, and nonalcoholic fatty liver disease. Our software is used to conduct drug research by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading provider for physiologically based pharmacokinetic modeling and simulation. (source)
Simulations Plus Employee Count
Number of Simulations Plus employees:
Last updated 8/31/19
Simulations Plus Revenue Totals
Simulations Plus annual revenue:
- FY 2019: $33.9 million
- FY 2018: $29.6 million
- FY 2017: $24.1 million
- FY 2016: $19.9 million
- FY 2015: $18.3 million
Simulations Plus annual net income:
- FY 2019: $8.5 million
- FY 2018: $8.9 million
- FY 2017: $5.7 million
- FY 2016: $4.9 million
- FY 2015: $3.8 million
Related posts:
Please note that some of these numbers are easier to find than others. A few of these Simulations Plus stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: